Cures Within Reach

Cures Within Reach's Virtual Pitch Event on October 6 Features Four Clinical Repurposing Trials

David C. Fajgenbaum, MD, MBA, MSc of Penn Medicine / CDRC and Incyte to be honored in 2022

These Diversity, Equity & Inclusion trials, funded by Cures Within Reach, include support from community-based organizations

These two new trials will join its Veterans Initiative research portfolio

Ten clinical trials starting soon in Diversity, Equity & Inclusion, including health disparities trials that engage community-based organizations

Cures Within Reach selecting at least 10 clinical trials to address health disparities and empower underrepresented researchers in the US and LMICs

Clinical Repurposing Trials in Vascular Malformations and Osteosarcoma Receive Funding

Lilly joins ReFRAME at Scripps Research/Calibr and CURE ID at the FDA and NCATS/NIH

Virtual Pitch Event on June 10 Features 4 Pediatric Clinical Repurposing Projects

ReFRAME at Scripps Research/Calibr and CURE ID at the FDA and NCATS/NIH to be honored during patient education events in 2021